Comment on: Effects of the FIFA 11+ Program on Physical Fitness in Youth and Adult Soccer Players: A Systematic Review and Meta‑analysis
Sports Medicine · 2026-09 · 56 (9) · 2341-2344
DOI: 10.1007/s40279-026-02489-2 ↗Kurz gefasst
Leserbrief in der Zeitschrift Sports Medicine, online erschienen am 03.08.2026. Verfasst von Rohit K Thapa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Symbiosis School of Sports Sciences, Symbiosis International (Deemed University), Pune, India. rohit.thapa@ssss.edu.in. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Symbiosis School of Sports Sciences, Symbiosis International (Deemed University), Pune, India. rohit.thapa@ssss.edu.in.
- CIPER, Faculty of Sport Sciences and Physical Education, University of Coimbra, Coimbra, Portugal.
- Portugese Air Force, Amadora, Portugal.
- Department of Physical Activity Sciences, Faculty of Education Sciences, Universidad Católica del Maule, Talca, Chile.
- Department of Physical Activity Sciences, Universidad de Los Lagos, Osorno, Chile.
Zitieren
APA
Thapa, R. K., Bruno, J., & Garcia-Carrillo, E. (2026). Comment on: Effects of the FIFA 11+ Program on Physical Fitness in Youth and Adult Soccer Players: A Systematic Review and Meta‑analysis. Sports Medicine, 56(9), 2341-2344. https://doi.org/10.1007/s40279-026-02489-2
Vancouver
Thapa RK, Bruno J, Garcia-Carrillo E. Comment on: Effects of the FIFA 11+ Program on Physical Fitness in Youth and Adult Soccer Players: A Systematic Review and Meta‑analysis. Sports Medicine. 2026;56(9):2341-2344. doi:10.1007/s40279-026-02489-2
BibTeX
@article{Thapa2026,
author = {Thapa, Rohit K and Bruno, João and Garcia-Carrillo, Exal},
title = {Comment on: Effects of the FIFA 11+ Program on Physical Fitness in Youth and Adult Soccer Players: A Systematic Review and Meta‑analysis},
journal = {Sports Medicine},
year = {2026},
volume = {56},
number = {9},
pages = {2341--2344},
doi = {10.1007/s40279-026-02489-2}
}
EUVIMED